This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Parseval, A.
Right arrow Articles by Elder, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Parseval, A.
Right arrow Articles by Elder, J. H.

 Previous Article  |  Next Article 

Journal of Virology, September 2004, p. 9132-9143, Vol. 78, No. 17
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.17.9132-9143.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Factors That Increase the Effective Concentration of CXCR4 Dictate Feline Immunodeficiency Virus Tropism and Kinetics of Replication

Aymeric de Parseval, Stacie Ngo, Peiqing Sun, and John H. Elder*

Department of Molecular Biology, The Scripps Research Institute, La Jolla, California

Received 22 September 2003/ Accepted 14 April 2004

The surface glycoprotein (gp95) of the feline immunodeficiency virus (FIV) binds in a strain-specific manner to several cell surface molecules, including CXCR4, heparan sulfate proteoglycans (HSPGs), DC-SIGN, and a 43-kDa cell surface receptor on T cells recently identified as CD134 by M. Shimojima et al. (Science 303:1192-1195, 2004). CXCR4 is the entry receptor in all known cases, and the other molecules act as binding receptors to help facilitate infection. In this report, we confirm and extend the findings regarding CD134 as a primary receptor for FIV. In addition, we show that temperature critically influences the binding properties of FIV gp95 to CXCR4 and HSPGs. The data show that gp95 of the field strain FIV-PPR bound to CXCR4 at 22°C, whereas binding was not detected at 4°C. In contrast, binding of the laboratory adapted FIV-34TF10 gp95 was observed at either 4°C or 22°C, albeit at increased levels at the higher temperature. The level of CXCR4 increased after the temperature was switched from 4 to 22°C, whereas the level of HSPGs decreased, resulting in higher binding of gp95 from both strains to CXCR4 and lower binding of gp95 of FIV-34TF10 to HSPGs (FIV-PPR gp95 does not bind to these molecules). The findings also show that HSPGs facilitate the CXCR4-mediated infectivity of CrFK and G355-5 cells by FIV-34TF10. These two nonlymphoid cell lines express very low levels of CXCR4 and are permissive to FIV-34TF10 but not to productive infection by FIV-PPR. However, overexpression of human CXCR4 in CrFK or G-355-5 cells resulted in extensive cell fusion and infection by FIV-PPR. Taken together, these findings indicate that factors that increase the effective concentration of CXCR4 enhance FIV infectivity and may involve (i) temperature or ligand-induced conformational changes in CXCR4 that enhance SU binding, (ii) coreceptor interactions with gp95 that either alter gp95 conformation to enhance CXCR4 binding and/or raise the localized concentration of receptor or ligand, or (iii) direct increase in CXCR4 concentration via overexpression.


* Corresponding author. Mailing address: Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA 92037. Phone for A. de Parseval: (858) 784-2932. Fax: (858) 784-2750. E-mail: aymeric{at}scripps.edu. Phone for J. Elder: (858) 784-8270. Fax: (858) 784-2750. E-mail: jelder{at}scripps.edu.


Journal of Virology, September 2004, p. 9132-9143, Vol. 78, No. 17
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.17.9132-9143.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Sundstrom, M., White, R. L., de Parseval, A., Sastry, K. J., Morris, G., Grant, C. K., Elder, J. H. (2008). Mapping of the CXCR4 Binding Site within Variable Region 3 of the Feline Immunodeficiency Virus Surface Glycoprotein. J. Virol. 82: 9134-9142 [Abstract] [Full Text]  
  • Reggeti, F., Ackerley, C., Bienzle, D. (2008). CD134 and CXCR4 expression corresponds to feline immunodeficiency virus infection of lymphocytes, macrophages and dendritic cells. J. Gen. Virol. 89: 277-287 [Abstract] [Full Text]  
  • Willett, B. J., McMonagle, E. L., Logan, N., Spiller, O. B., Schneider, P., Hosie, M. J. (2007). Probing the Interaction between Feline Immunodeficiency Virus and CD134 by Using the Novel Monoclonal Antibody 7D6 and the CD134 (Ox40) Ligand. J. Virol. 81: 9665-9679 [Abstract] [Full Text]  
  • Freer, G., Matteucci, D., Mazzetti, P., Tarabella, F., Catalucci, V., Bendinelli, M. (2007). Effects of feline immunodeficiency virus on feline monocyte-derived dendritic cells infected by spinoculation. J. Gen. Virol. 88: 2574-2582 [Abstract] [Full Text]  
  • Willett, B. J., McMonagle, E. L., Ridha, S., Hosie, M. J. (2006). Differential Utilization of CD134 as a Functional Receptor by Diverse Strains of Feline Immunodeficiency Virus.. J. Virol. 80: 3386-3394 [Abstract] [Full Text]  
  • de Parseval, A., Grant, C. K., Sastry, K. J., Elder, J. H. (2006). Sequential CD134-CXCR4 Interactions in Feline Immunodeficiency Virus (FIV): Soluble CD134 Activates FIV Env for CXCR4-Dependent Entry and Reveals a Cryptic Neutralization Epitope. J. Virol. 80: 3088-3091 [Abstract] [Full Text]  
  • Dowling, R. J. O., Bienzle, D. (2005). Gene-expression changes induced by Feline immunodeficiency virus infection differ in epithelial cells and lymphocytes. J. Gen. Virol. 86: 2239-2248 [Abstract] [Full Text]  
  • Joshi, A., Garg, H., Tompkins, M. B., Tompkins, W. A. (2005). Preferential Feline Immunodeficiency Virus (FIV) Infection of CD4+ CD25+ T-Regulatory Cells Correlates both with Surface Expression of CXCR4 and Activation of FIV Long Terminal Repeat Binding Cellular Transcriptional Factors. J. Virol. 79: 4965-4976 [Abstract] [Full Text]  
  • de Parseval, A., Chatterji, U., Sun, P., Elder, J. H. (2004). Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. Proc. Natl. Acad. Sci. USA 101: 13044-13049 [Abstract] [Full Text]